Micol Rothman, MD

Professional Titles

• Associate Professor of Medicine and Radiology

Recognitions

• RIsing Star, Department of Medicine (2014)
• 5280 Top Doctors, 5280 Magazine (2017)
• Innovation Award, Department of Medicine (2019)

Research Interests

My research interests include care gaps in osteoporosis, health of gender diverse patients and the effects of sex steroids (estrogen and testosterone) on bone health.

Publications

• Rothman MS, Hamnvik OR, Davidge-Pitts C, Safer JD, Ariel D, Tangpricha V, Abramowitz J, Soe K, Sarvaideo J, Kelley C, Irwig MS, Iwamoto SJ. Revisiting Injectable Estrogen Dosing Recommendations for Gender-Affirming Hormone Therapy. Transgend Health. 2024 Dec;9(6):463-465. PubMed PMID: 39735380
• Kushchayeva Y, Kushchayev S, Dunn K, Pestun I, Rothman MS, Lewiecki EM. Bone Health ECHO Case Report: Significant Elevation in Bone Turnover Markers and Progression of Vertebral Fractures After Denosumab Discontinuation Followed by a PTH-Analog. J Clin Densitom. 2024 Dec 12;28(1):101551. [Epub ahead of print] PubMed PMID: 39731882
• Rothman MS, Ariel D, Kelley C, Hamnvik OR, Abramowitz J, Irwig MS, Soe K, Davidge-Pitts C, Misakian AL, Safer JD, Iwamoto SJ. The Use of Injectable Estradiol in Transgender and Gender Diverse Adults: A Scoping Review of Dose and Serum Estradiol Levels. Endocr Pract. 2024 Sep;30(9):870-878. PubMed PMID: 38782202
• Iwamoto SJ, Rice JD, Moreau KL, Cornier MA, Wierman ME, Mancuso MP, Gebregzabheir A, Hammond DB, Rothman MS. The association of gender-affirming hormone therapy duration and body mass index on bone mineral density in gender diverse adults. J Clin Transl Endocrinol. 2024 Jun;36:100348. PubMed PMID: 38756206
• Roy MK, Bothwell S, Kelsey MM, Ma NS, Moreau KL, Nadeau KJ, Rothman MS, Nokoff NJ. Bone Density in Transgender Youth on Gender-Affirming Hormone Therapy. J Endocr Soc. 2024 Mar 12;8(5):bvae045. PubMed PMID: 38562129
• Billups SJ, Fixen DR, Schilling LM, El-Sheikh A, Marcus AM, Rothman MS. Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare System. J Gen Intern Med. 2024 Jun;39(8):1407-1413. PubMed PMID: 38100010
• Lee D, Carrera EJ, Hagens R, Yeung G, Garvan CW, Rothman MS, Akuthota V. Serum cortisol level to screen for significant hypothalamic-pituitary-adrenal axis suppression in patients receiving multiple steroid injections. Pain Med. 2024 Feb 1;25(2):97-103. PubMed PMID: 37819765
• Iwamoto SJ, Rothman MS, T'Sjoen G, Defreyne J. Approach to the Patient: Hormonal Therapy in Transgender Adults With Complex Medical Histories. J Clin Endocrinol Metab. 2024 Jan 18;109(2):592-602. PubMed PMID: 37683089
• Hoffner-Heinike A, Iwamoto SJ, Saxon DR, Cogdall NA, Davies RD, Lee RS, Chiappone A, Thomas JF, Rothman MS. ECHO "Bootcamp": An Innovative Training Model to Onboard Providers in the Care of Gender Diverse Patients. Telemed J E Health. 2024 Feb;30(2):430-437. PubMed PMID: 37499094
• Swanson CM, Krohn K, Wiseman A, Rothman MS. New Human Leukocyte Antigen (HLA) Antibody Formation and Creatinine Elevation With Abaloparatide in Kidney Transplant Recipient. JBMR Plus. 2023 Dec;7(12):e10814. PubMed PMID: 38130769
• Billups SJ, Fixen DR, Schilling LM, El-Sheikh A, Marcus AM, Rothman MS. Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare System. J Gen Intern Med. 2023 Dec 15. [Epub ahead of print] PubMed PMID: 38100010
• Lee D, Carrera EJ, Hagens R, Yeung G, Garvan CW, Rothman MS, Akuthota V. Serum Cortisol Level to Screen for Significant Hypothalamic-Pituitary-Adrenal Axis Suppression in Patients Receiving Multiple Steroid Injections. Pain Med. 2023 Oct 11. [Epub ahead of print] PubMed PMID: 37819765
• Iwamoto SJ, Rothman MS, T'Sjoen G, Defreyne J. Approach to the Patient: Hormonal Therapy in Transgender Adults with Complex Medical Histories. J Clin Endocrinol Metab. 2023 Sep 8. [Epub ahead of print] PubMed PMID: 37683089
• Hoffner-Heinike A, Iwamoto SJ, Saxon DR, Cogdall NA, Davies RD, Lee RS, Chiappone A, Thomas JF, Rothman MS. ECHO "Bootcamp": An Innovative Training Model to Onboard Providers in the Care of Gender Diverse Patients. Telemed J E Health. 2023 Jul 27. [Epub ahead of print] PubMed PMID: 37499094
• Iwamoto SJ, Defreyne J, Kaoutzanis C, Davies RD, Moreau KL, Rothman MS. Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults. Ther Adv Endocrinol Metab. 2023;14:20420188231166494. PubMed PMID: 37113210
• Billups SJ, Thai VK, Denkins J, Dettman IC, Rothman MS. Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids. Arch Osteoporos. 2023 Mar 1;18(1):38. PubMed PMID: 36856881
• ElSheikh A, Rothman MS, Santoro N. Postmenopausal Osteoporosis: What the Obstetrician/Gynecologist Should Know. Contemporary ObGyn May 2023. Vol 68:05
• Elsheikh A, Rothman MS. Testosterone Replacement Therapy for Treatment of Osteoporosis in Men. Faculty Reviews 2023 12:(18) https://doi.org/10.12703/r/12-18
• Lewiecki EM, Anderson PA, Bilezikian JP, Binkley N, Cheung AM, Imel EA, Krueger D, McClung MR, Miller PD, Rothman MS. Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases. J Clin Densitom. 2022 Jan-Mar;25(1):3-19. PubMed PMID: 34785102
• Zaman A, Rothman MS, Billups SJ. Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Arch Osteoporos. 2022 Jan 20;17(1):18. PubMed PMID: 35050418
• Sotiros AR, Iwamoto SJ, Rothman MS, Lee RS. A Novel Multidisciplinary Model of Care for Transgender and Gender Diverse Adults: Program Description and Patient Perspectives. Transgend Health. 2022 Jun;7(3):276-281. PubMed PMID: 36643065
• McClung MR, Rothman MS, Lewiecki EM, Hanley DA, Harris ST, Miller PD, Kendler DL. The role of osteoanabolic agents in the management of patients with osteoporosis. Postgrad Med. 2022 Aug;134(6):541-551. PubMed PMID: 35635798
• Zaman A, Rothman MS, Billups SJ. Stop the denosumab delay! The effect of implementing an automatic reminder in the electronic medical record. Arch Osteoporos. 2022 Jan 20;17(1):18. PubMed PMID: 35050418
• Lewiecki EM, Anderson PA, Bilezikian JP, Binkley N, Cheung AM, Imel EA, Krueger D, McClung MR, Miller PD, Rothman MS. Proceedings of the 2021 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis and Metabolic Bone Diseases. J Clin Densitom. 2022 Jan-Mar;25(1):3-19. PubMed PMID: 34785102
• Sotiros A, Iwamoto SJ, Rothman MS, Lee R A Novel Model Multidisciplinary Model of Care for Transgender and Gender Diverse Adults: Program Description and Patient Perspectives Transgender Health 2021
• Zaman A, Rothman MS. Postmenopausal Hyperandrogenism: Evaluation and Treatment Strategies. Endocrinol Metab Clin North Am. 2021 Mar;50(1):97-111. PubMed PMID: 33518189
• Iwamoto SJ, Grimstad F, Irwig MS, Rothman MS. Routine Screening for Transgender and Gender Diverse Adults Taking Gender-Affirming Hormone Therapy: a Narrative Review. J Gen Intern Med. 2021 May;36(5):1380-1389. PubMed PMID: 33547576
• Lewiecki EM, Rothman MS. COVID-19, Medical Education, and Bone Health: Insights From Project ECHO. J Clin Densitom. 2020 Jul-Sep;23(3):338-339. PubMed PMID: 32448715
• Iwamoto SJ, Rothman MS, Duan S, Baker JC, Mumm S, Whyte MP. Early-onset Paget's disease of bone in a Mexican family caused by a novel tandem duplication (77dup27) in TNFRSF11A that encodes RANK. Bone. 2020 Apr;133:115224. PubMed PMID: 31923705
• Wallace MA, Hammes A, Rothman MS, Trizno AA, Jones CD, Cumbler E, McDevitt K, Carlson NE, Stoneback JW. Fixing a Fragmented System: Impact of a Comprehensive Geriatric Hip Fracture Program on Long-Term Mortality. Perm J. 2019;23. PubMed PMID: 31702983
• Iwamoto SJ, Defreyne J, Rothman MS, Van Schuylenbergh J, Van de Bruaene L, Motmans J, T'Sjoen G. Health considerations for transgender women and remaining unknowns: a narrative review. Ther Adv Endocrinol Metab. 2019;10:2042018819871166. PubMed PMID: 31516689
• Rothman MS, Olenginski TP, Stanciu I, Krohn K, Lewiecki EM. Lessons learned with Bone Health TeleECHO: making treatment decisions when guidelines conflict. Osteoporos Int. 2019 Dec;30(12):2401-2406. PubMed PMID: 31471665
• Rothman MS, Iwamoto SJ. Bone Health in the Transgender Population. Clin Rev Bone Miner Metab. 2019 Jun;17(2):77-85. PubMed PMID: 31452648
• Iwamoto SJ, T'Sjoen G, Safer JD, Davidge-Pitts CJ, Wierman ME, Glodowski MB, Rothman MS. Letter to the Editor: "Progesterone Is Important for Transgender Women's Therapy-Applying Evidence for the Benefits of Progesterone in Ciswomen". J Clin Endocrinol Metab. 2019 Aug 1;104(8):3127-3128. PubMed PMID: 30860591
• Schorr M, Drabkin A, Rothman MS, Meenaghan E, Lashen GT, Mascolo M, Watters A, Holmes TM, Santoso K, Yu EW, Misra M, Eddy KT, Klibanski A, Mehler P, Miller KK. Bone mineral density and estimated hip strength in men with anorexia nervosa, atypical anorexia nervosa and avoidant/restrictive food intake disorder. Clin Endocrinol (Oxf). 2019 Jun;90(6):789-797. PubMed PMID: 30817009
• Friedly JL, Comstock BA, Heagerty PJ, Bauer Z, Rothman MS, Suri P, Hansen R, Avins AL, Nedeljkovic SS, Nerenz DR, Akuthota V, Jarvik JG. Systemic effects of epidural steroid injections for spinal stenosis. Pain 2018 Jan 30.
• Drabkin A, Rothman M, Laging M, Watters A, Mascolo M, Mehler P. “Sarcopenia in Patients with Eating Disorders Predicts Low Bone Mineral Density and Prolonged Hospital Stay.” Eating Disorders Research Society. Sydney Australia October 2018.
• Billups SJ, Rothman MS, Marcus A, Wallace MA, Schilling LM. “Implementing a Fracture Liaison Service in a Large Academic Medical Center.” 2018 ACCP Global Conference on Clinical Pharmacy. Seattle, WA. Oct 20-23 2018.
• Zaman A, Thomas E, Rothman M, Kerr J. “Rethinking Glucocorticoids to Treat Amiodarone-Induced Thyrotoxicosis: A Case Report. “ American Thyroid Association Annual Meeting Washington, DC October 2018.
• Zaman A and Rothman M. “True, True, and Unrelated? A Case of Oral Tooth Resorptive Disorder and Osteoporosis.” Santa Fe Bone Symposium Fellows Conference. Santa Fe, NM August 2018.
• Wallace MA, Rothman MS, Trizno AA, Jones CD, Cumbler E, McDevitt K, Stoneback JW. “Fewer Fatal Fractures: Impact of Geriatric Hip Fracture Program on 1-Year Mortality.” American College of Physicians Internal Medicine Meeting New Orleans, LA April 2018.
• Glodowski MB, Iwamoto SJ, Alaniz VI, Huguelet PS, Rothman, MS. “Rates of Cervical Cancer Screening in Transgender Male Patients at the University of Colorado Hospital: A Quality Improvement Exercise.” Endocrine Society Annual Meeting Chicago, IL March 2018
• Iwamoto SJ, Wierman ME, Bessesen DB, Rothman MS. “Increased Prevalence of Obesity Among Adult Transgender Patients at Three Denver-area Hospitals: Shedding Light on a Health Disparity” Endocrine Society Annual Meeting Chicago, IL March 2018
• Rothman MS, Stoneback JW, Trizno AA, Wallace MA. “Establishment of a Comprehensive Geriatric Hip Fracture Program: One Year Follow Up.” Endocrine Society Annual Meeting Chicago, IL March 2018
• Iwamoto S, Rothman MS, Duan S, Mumm S, Burr K, Whyte MP “High Turnover Bone Disease Due to a Novel 27-Base Pair Tandem Duplication in TNFRSF11A Leading to Constitutively Active RANK” ASBMR Annual Meeting Poster September 2017
• Rothman MS, Kohrt WM, Saint-Phard D, “Evidence of A ‘Male Athlete Triad’ In Competitive Triathletes.” American College of Sports Medicine Annual Meeting. Denver, CO June 2017.
• Iwamoto S, Rothman MS, Duan S, Mumm S, Burr K, Whyte MP “High Turnover Bone Disease Due to a Novel 27-Base Pair Tandem Duplication in TNFRSF11A Leading to Constitutively Active RANK” Oral Session Endocrine Society Annual Meeting Orlando, FL April 2017.
• Drabkin A, Rothman MS, Wassenaar E, Mascolo M, Mehler PS. Assessment and clinical management of bone disease in adults with eating disorders: a review. J Eat Disord. 2017;5:42. PubMed PMID: 29214023
• Rothman MS, Lewiecki EM, Miller PD. Bone Density Testing Is the Best Way to Monitor Osteoporosis Treatment. Am J Med. 2017 Oct;130(10):1133-1134. PubMed PMID: 28687261
• Saxon DR, Rothman MS, Russell DW, Wilson JD. “Middlesex in Clinic: A Novel Steroid 5-alpha reductase 2 Gene Mutation in a Patient Desiring Gender Reassignment at an Uncharacteristically Late Age.” Endocrine Society and International Society of Endocrinology Meeting: Chicago, IL. June 2014
• Rothman MS, Miller PD, Lewiecki E, Bilezikian JP. Bone density testing: science, the media, and patient care. Curr Osteoporos Rep. 2014 Jun;12(2):227-9. PubMed PMID: 24659466
• Weickhardt AJ, Doebele RC, Purcell WT, Bunn PA, Oton AB, Rothman MS, Wierman ME, Mok T, Popat S, Bauman J, Nieva J, Novello S, Ou SH, Camidge DR. Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients. Cancer. 2013 Jul 1;119(13):2383-90. PubMed PMID: 23585220
• Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED. Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes. Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. PubMed PMID: 23144328
• HIV infection and osteoporosis: pathophysiology, diagnosis, and treatment options. Rothman MS, Bessesen MT. Curr Osteoporos Rep. 2012 Dec;10(4):270-7. doi: 10.1007/s11914-012-0125-0.
• Rothman MS and Wierman ME. “Amenorrhea” in Endocrine Secrets Sixth Edition Editor: Michael McDermott MD in press.
• Bridenstine M, Bell BK and Rothman MS. “Gynecomastia” in Endocrine Secrets Sixth Edition Editor Michael Mc Dermott, MD in press
• Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer. Weickhardt AJ, Rothman MS, Salian-Mehta S, Kiseljak-Vassiliades K, Oton AB, Doebele RC, Wierman ME, Camidge DR. Cancer. 2012 Nov 1;118(21):5302-9. doi: 10.1002/cncr.27450. Epub 2012 Apr 4. PMID: 22488744 [PubMed - indexed for MEDLINE]
• Kartalija M, Ovrutsky AR, Bryan CL, Pott GB, Fantuzzi G, Thomas J, Strand MJ, Bai X, Ramamoorthy P, Rothman MS, Nagabhushanam V, McDermott M, Levin AR, Frazer-Abel A, Giclas PC, Korner J, Iseman MD, Shapiro L, Chan ED. “Patients with Non-Tuberculous Mycobacterial Lung Disease Exhibit Unique Body and Immune Phenotypes. Am J Respir Crit Care Med. Am J Respir Crit Care Med. 2013 Jan 15;187(2):197-205. Epub November 2012
• Weickhardt AJ, Rothman MS, Salian-Mehta S, Kiseljak-Vassiliades K, Oton AB, Doebele RC, Wierman ME, Cambidge DR. “Rapid and Reversible Hypogonadism secondary to Crizotinib Use in Men with Metastatic Non-small cell Lung Cancer.” Cancer, 2012, in press.
• Rothman MS and Wierman, ME. “How Should Postmenopausal Androgen Excess Be Evaluated?” Clinical Endocrinology August 2011: 75(2) 160-164.
• Sigmon CH., Pudwill N, Rothman, MS, Santos K Yin, X, Saint-Phard D. “Is There Evidence of Disordered Eating in High-endurance Male Collegiate Athletes.” PM&R Journal (Supplement) Vol. 3, Iss. 1091, 2011, S236. Poster 191
• Rothman MS, Carlson NE, Xu M, Wang C, Swerdloff R, Lee P, Goh VHH, Ridgway EC, Wierman ME. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids January 2011 (Epub Nov 9, 2010) 76(1-2) 177:182.
• Rothman MS and Wierman, ME. “How Should Postmenopausal Androgen Excess Be Evaluated?” Clinical Endocrinology 2011 (in press)
• Huang J, Rothman MS and Wierman ME “Premature Gonadal Insufficiency” in Immunoendocrinology: Scientific and Clinical Aspects Editor: George S. Eisenbarth 2011 Humana Press 519-534.
• Friedrich J, Rothman MS, Pudwill N, and Saint-Phard D. “The Female Athlete Triad:Male Variant” American College of Sports Medicine 58th Annual Meeting Denver, CO. Accepted, pending presentation May 2011.
• Mansoori LS, Catel CP, Rothman,MS Bisphosphonate Treatment in Polyostotic Fibrous Dysplasia of the Cranium: Case Report and Literature Review. Endocr Pract 2010 June 21:1-14.
• Rothman MS, Wierman ME. "Low Testosterone levels and the risk of metabolic syndrome in men" Aging Health 2009 5(2) In press.
• Micol S. Rothman, Nichole E. Carlson, Mei Xu, Christina Wang, Ronald Swerdloff, Paul Lee, Victor Goh, E.Chester Ridgway, and Margaret E. Wierman. "Reexamination of Testosterone, Dihydrotestosterone and Estradiol Levels Measured by Liquid Chromatography Tandem Mass Spectrometry across the Menstrual Cycle, in Postmenopausal Women and Men across the Lifespan."
• Rothman MS and Wierman ME. Low Testosterone Levels and the Risk of Metabolic Syndrome in Men. Aging Health 2009 5(2) 217-225.
• Bell, BK and Rothman, MS. "Gynecomastia" in Endocrine Secrets Fifth Edition Editor Michael McDermott, MD 2009 Mosby 394-398.
• Rothman, MS and Wierman, ME “Amenorrhea ” in Endocrine Secrets Fifth Edition Editor Michael McDermott, MD 2009 Mosby 399-405.
• Wrote endocrine MKSAP questions for Board review
• Rothman MS, Wierman ME. “Female hypogonadism: evaluation of the hypothalamic-pituitary-ovarian axis. Pituitary 2008; 11(2)163-169.
• Rothman MS, Arciniegas DB, Filley CM and Wierman ME. "The Neuroendocrine Effects of Traumatic Brain Injury" in The Journal of Neuropsychiatry and Clinical Neurosciences
• Rothman MS and Wierman ME Testosterone and cardiovascular disease in men. Aging Health June 2007 3:3: 375-381.
• Rothman MS and Wierman ME. The role of gonadotropin releasing hormone in normal and pathologic endocrine processes. Curr Opin Endocrinol Diabetes Obes. 2007Aug;14(4):306-10.
• Rothman MS, Arciniegas DB, Filley CM, Wierman ME. The Neuroendocrine Effects of Traumatic Brain Injury. J Neuropsychiatry Clin Neurosci November 2007 19:363-372.
• Bridenstine M, and Rothman MS. “Gynecomastia” in Endocrine Secrets Seventh Edition Editor Michael Mc Dermott, MD
• Rothman MS and Wierman ME. “Amenorrhea” in Endocrine Secrets Seventh Edition Editor: Michael McDermott MD In Press
• Rothman MS and Iwamoto SJ. “Gender-Affirming Treatment for Adults with Gender Incongruence and Gender Dysphoria” in Endocrine Secrets Seventh Edition Editor: Michael McDermott MD In Press

Professional Memberships

• Endocrine Society, Member
• ASBMR, Member
• ISCD, Member
• WPATH/USPATH, Member

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

UCHealth Anschutz Outpatient Pavilion - Anschutz Medical Campus
1635 Aurora Ct
Aurora, CO 80045
720-848-0000

UCHealth Diabetes and Endocrinology Clinic - Anschutz Medical Campus
1635 Aurora Ct
6th Floor
Aurora, CO 80045
720-848-2650

Hospital Affiliation

• University of Colorado Hospital

Specialty Information

Specialties

• Endocrinology, Diabetes and Metabolism, Board Certification (2005, 2015)
• Internal Medicine, Board Certification (, 2012)
• Clinical Densitometry , Certificate (0001)

Conditions & Treatments

• Endocrine System (Hormones)
• Endocrine System (Hormones) - Adult Type 1 Diabetes
• Endocrine System (Hormones) - Adult Type 2 Diabetes
• Endocrine System (Hormones) - Endocrine Cancer (Parathyroid, Adrenal, Carcinoid)
• Endocrine System (Hormones) - Thyroid Disease
• Endocrine System (Hormones) - Adrenal Diseases
• Women's Health - Hormone Replacement Therapy
• Women's Health - Menopause
• Endocrine System (Hormones) - Osteoporosis
• Women's Health
• Endocrine System (Hormones) - Thyroid Cancer
• Transgender Health for Adults
• Bones, Joints and Muscles
• Bones, Joints and Muscles - Osteoporosis